What You Should Know:
– R1, a provider of healthcare revenue management automation, today announced an agreement to acquire Phare Health, a technology company specializing in AI-native solutions for inpatient coding and clinical documentation improvement (CDI).
– The acquisition is a significant step in R1’s strategy to comprehensively automate the revenue cycle and move closer to real-time adjudication of medical claims.
Unifying Clinical Documentation and Financial Intelligence
The acquisition is poised to create the most compelling AI-native clinical intelligence solution in the market by combining Phare Health’s innovative technology in CDI and autonomous complex coding with R1’s scale and market-leading DRG Validation (DRG-V) solution.
Joe Flanagan, Chief Executive Officer of R1, emphasized the strategic alignment: “R1 has always been at the forefront of revenue cycle innovation, and our partnership with Phare Health marks a pivotal step in unifying the full spectrum of RCM, from clinical documentation to financial intelligence.”
The combined entity aims to reduce administrative friction and risk, providing health systems with dependable, compliant solutions.
The Power of Physician-Led, Context-Aware AI
Phare Health was founded by healthcare and AI leaders with experience from Google DeepMind and prominent AI research institutions. Their platform utilizes a transformative approach to tackle the most complex inpatient coding cases:
- Holistic Patient Fingerprint: Unlike traditional keyword extraction systems, the AI engine reads all unstructured and structured data points to build a comprehensive view of the patient journey.
- Context-Aware Decisions: This data is cross-referenced with guidelines and coding policies to enable context-aware coding decisions with a full evidence trail.
Dr. Martin Seneviratne, Co-Founder and Co-CEO of Phare Health, noted that the platform “reasons over a patient’s full medical record, drawing upon guidelines and clinical knowledge to ‘translate’ between two complex languages: clinical and coding.”.
Accelerating Innovation in the R37 Lab
Following the close of the transaction, expected by the end of October 2025, the Phare Health team will join R1’s R37 innovation lab. R1’s R37 AI lab already has agentic applications in production with select clients, achieving autonomous coding accuracy rates as high as 97% for certain service lines like emergency room and physician office visits. Bringing the Phare Health team into the R37 lab is expected to further accelerate the development of next-generation AI applications.
